| Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial JJ Feld, C Kandel, MJ Biondi, RA Kozak, MA Zahoor, C Lemieux, ... The Lancet Respiratory Medicine 9 (5), 498-510, 2021 | 214 | 2021 |
| Surface and air contamination with severe acute respiratory syndrome coronavirus 2 from hospitalized coronavirus disease 2019 patients in Toronto, Canada, March–May 2020 JD Kotwa, AJ Jamal, H Mbareche, L Yip, P Aftanas, S Barati, NG Bell, ... The Journal of infectious diseases 225 (5), 768-776, 2022 | 18 | 2022 |
| Sensitivity of midturbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) AJ Jamal, M Mozafarihashjin, E Coomes, S Anceva-Sami, S Barati, ... Infection Control & Hospital Epidemiology 42 (8), 1001-1003, 2021 | 17 | 2021 |
| Surface and air contamination with SARS-CoV-2 from hospitalized COVID-19 patients in Toronto, Canada JD Kotwa, AJ Jamal, H Mbareche, L Yip, P Aftanas, S Barati, NG Bell, ... medRxiv, 2021.05. 17.21257122, 2021 | 15 | 2021 |
| Peginterferon-lambda for the treatment of COVID-19 in outpatients JJ Feld, C Kandel, MJ Biondi, RA Kozak, MA Zahoor, C Lemieux, ... MedRxiv, 2020.11. 09.20228098, 2020 | 7 | 2020 |
| Evaluation of mobile real-time polymerase chain reaction tests for the detection of severe acute respiratory syndrome coronavirus 2 C Onyilagha, H Mistry, P Marszal, M Pinette, D Kobasa, N Tailor, ... Scientific Reports 11 (1), 9387, 2021 | 5 | 2021 |
| Surface and air contamination with SARS-CoV-2 from hospitalized COVID-19 patients in Toronto, Canada (preprint) JD Kotwa, AJ Jamal, H Mbareche, L Yip, P Aftanas, S Barati, NG Bell, ... | | 2021 |
| Peginterferon-lambda for the treatment of COVID-19 in outpatients (preprint) JJ Feld, C Kandel, MJ Biondi, RA Kozak, MA Zahoor, C Lemieux, ... | | 2020 |
